Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Long-Term Study of K-877 ER in Dyslipidemia with High Triglycerides
jRCT2031200343Phase 3Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of pemafibrate in dyslipidemia and hypertriglyceridemia (2 arms), sponsored by Kowa Company, Ltd. Started Feb 2021; status: completed.
02
Drugs
pemafibrate
03
Conditions
dyslipidemiahypertriglyceridemia
Beyond the preview
Go deeper on jRCT2031200343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031200343.